CymaBay Therapeutics Inc (NASDAQ:CBAY)

11.90
Delayed Data
As of 11:29am ET
 -0.09 / -0.75%
Today’s Change
3.16
Today|||52-Week Range
15.59
+29.35%
Year-to-Date
No recent news for CymaBay Therapeutics Inc.

Today’s Trading

Previous close11.99
Today’s open11.97
Day’s range11.81 - 12.18
Volume121,858
Average volume (3 months)1,082,466
Market cap$831.2M
Data as of 11:29am ET, 04/26/2018

Growth & Valuation

Earnings growth (last year)-37.35%
Earnings growth (this year)+21.27%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book89.27

Competitors

 Today’s
change
Today’s
% change
ACETAceto Corp+0.02+0.80%
DITAMCON Distributing C...+0.60+0.63%
AGXArgan Inc+1.00+2.62%
NUSNU Skin Enterprises ...+0.29+0.40%
Data as of 11:45am ET, 04/26/2018

Financials

Next reporting dateMay 10, 2018
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$0.00
Annual profit (last year)-$26.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer, CFO &
Director
Sujal Shah
Chief Scientific Officer &
Senior Vice President
Charles A. McWherter
Corporate headquarters
Newark, California

Forecasts